A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo
Top Cited Papers
- 12 February 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Biotechnology
- Vol. 36 (3), 258-264
- https://doi.org/10.1038/nbt.4071
Abstract
Nanoscale robots have potential as intelligent drug delivery systems that respond to molecular triggers1,2,3,4. Using DNA origami we constructed an autonomous DNA robot programmed to transport payloads and present them specifically in tumors. Our nanorobot is functionalized on the outside with a DNA aptamer that binds nucleolin, a protein specifically expressed on tumor-associated endothelial cells5, and the blood coagulation protease thrombin within its inner cavity. The nucleolin-targeting aptamer serves both as a targeting domain and as a molecular trigger for the mechanical opening of the DNA nanorobot. The thrombin inside is thus exposed and activates coagulation at the tumor site. Using tumor-bearing mouse models, we demonstrate that intravenously injected DNA nanorobots deliver thrombin specifically to tumor-associated blood vessels and induce intravascular thrombosis, resulting in tumor necrosis and inhibition of tumor growth. The nanorobot proved safe and immunologically inert in mice and Bama miniature pigs. Our data show that DNA nanorobots represent a promising strategy for precise drug delivery in cancer therapy.Keywords
This publication has 37 references indexed in Scilit:
- Principles of nanoparticle design for overcoming biological barriers to drug deliveryNature Biotechnology, 2015
- Dynamic DNA devices and assemblies formed by shape-complementary, non–base pairing 3D componentsScience, 2015
- Challenges and opportunities for structural DNA nanotechnologyNature Nanotechnology, 2011
- A synthetic icosahedral DNA-based host–cargo complex for functional in vivo imagingNature Communications, 2011
- Nucleolin binds to a subset of selenoprotein mRNAs and regulates their expressionNucleic Acids Research, 2010
- The Nucleolin Targeting Aptamer AS1411 Destabilizes Bcl-2 Messenger RNA in Human Breast Cancer CellsCancer Research, 2008
- The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosinBlood, 2006
- Folding DNA to create nanoscale shapes and patternsNature, 2006
- Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic TherapyScience, 2005
- Structure-Switching Signaling AptamersJournal of the American Chemical Society, 2003